Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).

Ramalingam S, Crawford J, Chang A, Manegold C, Perez-Soler R, Douillard JY, Thatcher N, Barlesi F, Owonikoko T, Wang Y, Pultar P, Zhu J, Malik R, Giaccone G; FORTIS-M Study Investigators..

Ann Oncol. 2013 Nov;24(11):2875-80. doi: 10.1093/annonc/mdt371.

2.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group..

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

3.

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer.

Pericay Pijaume C, Escudero Emperador P, Bastús Piulats R, Campos Cervera JM, Esquerdo Galiana G, Gallén Castillo M, Alfaro Gamero J, Dotor Navarro E, Pisa Gatell A, Guasch Jordán I, Saigí Grau E; ACROSS group..

Clin Transl Oncol. 2011 Jan;13(1):61-6.

PMID:
21239357
4.

Repeat mediastinoscopy in all its indications: experience with 96 patients and 101 procedures.

Call S, Rami-Porta R, Obiols C, Serra-Mitjans M, Gonzalez-Pont G, Bastús-Piulats R, Quintana S, Belda-Sanchis J.

Eur J Cardiothorac Surg. 2011 Jun;39(6):1022-7. doi: 10.1016/j.ejcts.2010.10.019. Review.

PMID:
21112217
5.

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

Carles Galcerán J, Bastus Piulats R, Martín-Broto J, Maroto Rey P, Nogué Aligué M, Domenech Santasusana M, Arcusa Lanza A, Bellmunt Molins J, Colin C, Girard A.

Clin Transl Oncol. 2005 Mar;7(2):66-73.

PMID:
15899211
6.

Remediastinoscopy after induction chemotherapy in non-small cell lung cancer.

Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, Cirera-Nogueras L, González-Pont G.

Ann Thorac Surg. 2000 Aug;70(2):391-5.

PMID:
10969650
7.

[Colitis induced by non-steroidal anti-inflammatory agents].

Rodríguez Carballeira M, Coll Roldua I, Muñoz Rodríguez FJ, Bastus Piulats R, Cirera Noguera L, Espinós Pérez JC.

An Med Interna. 1995 Oct;12(10):513. Spanish. No abstract available.

PMID:
8519946
8.

[Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].

Germa Lluch JR, Bastus Piulats R.

Actas Urol Esp. 1987 May-Jun;11(3):293-8. Spanish. No abstract available.

PMID:
2444075
Items per page

Supplemental Content

Loading ...
Support Center